Virtu Financial’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Virtu Financial’s Portfolio ETTX Stock Details ETTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-20,027	Closed	-$44K	–	2548
2022 Q2	$44K	Buy	+20,027	New	+$40K	﹤0.01%	1157
2022 Q1	–	Sell	-24,367	Closed	-$53K	–	2431
2021 Q4	$53K	Sell	24,367 -7,264	-23%	-$19.6K	0.01%	1330
2021 Q3	$106K	Buy	+31,631	New	+$85.8K	0.01%	1131
2021 Q1	–	Sell	-146,128	Closed	-$361K	–	2260
2020 Q4	$361K	Buy	146,128 +120,887	+479%	+$238K	0.04%	557
2020 Q3	$51K	Buy	+25,241	New	+$72K	0.01%	822

Virtu Financial's ETTX Position: Q3 2022 in Review

Virtu Financial sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2022, closing a stake of 20,027 shares — an estimated $44K sold.

Virtu Financial first reported a position in ETTX in Q3 2020 and held it in 5 quarters. The position peaked at $361K in Q4 2020. 0 funds tracked by Wall St. Rank hold ETTX as of Q3 2022.

Virtu Financial reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2022 after selling out during the quarter.
Virtu Financial sold 20,027 Entasis Therapeutics Holdings Inc. shares in Q3 2022, an estimated $44K.
Virtu Financial first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2020 and held it in 5 quarters.
Virtu Financial's Entasis Therapeutics Holdings Inc. position peaked at $361K in Q4 2020.
0 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2022.

Based on Virtu Financial's 13F filing for Q3 2022, filed 7 Nov 2022.